Ledger.Open graph →
SEC Form D · filed April 10, 2020

Exalys Therapeutics, Inc

Offering
$25.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Takeshi T. Takahashi · San Diego, CADirectorMichael Sanders · San Diego, CAExecNicole Vitullo · San Diego, CADirectorLynne Rollins · Westport, CTExecEckard Weber, M.D · San Diego, CADirectorDennis Podlesak · Menlo Park, CAExec · DirectorBrian T. Slingsby · Fujisawa, Kanagawa, M0DirectorRick Orr · San Francisco, CADirectorTakeshi T. Takahashi · San Diego, CADirectorEckard Weber, M.D · Westport, CTDirectorMichael Sanders · Los Angeles, CAExecNicole Vitullo · BRANFORD, CTDirectorDennis Podlesak · San Francisco, CAExec · DirectorBrian T. Slingsby · Fujisawa, Kanagawa, M0DirectorRick Orr · Bozeman, MTDirectorLynne Rollins · Carlsbad, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗